Iris S. H. Kloots

Impact of <scp>DNA</scp> damage repair defects and aggressive variant features on response to carboplatin‐based chemotherapy in metastatic castration‐resistant prostate cancer

Peter H. J. Slootbeek, Marleen L. Duizer, Maarten J. van der Doelen et al. · International Journal of Cancer · 2020 · 36 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial

Sandra van Wilpe, Iris S. H. Kloots, P.H.J. Slootbeek et al. · Annals of Oncology · 2024 · 33 citations · Full text

Life Sciences, Immunology, Oncology +17

Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer

Sofie H. Tolmeijer, Sandra van Wilpe, Maartje J. Geerlings et al. · European Urology Oncology · 2023 · 20 citations · Full text

Medicine, Immunology, Oncology +17

Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer

Peter H. J. Slootbeek, Iris S. H. Kloots, Minke Smits et al. · British Journal of Cancer · 2021 · 15 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer

Levi Groen, Iris S. H. Kloots, David Englert et al. · International Journal of Molecular Sciences · 2023 · 15 citations · Full text

Medicine, Cancer Biology, Oncology +17